Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study

A prospective, single-arm, non-randomized, single-center, open-label, treat and resect study following patients through surgical resection. The study is designed to evaluate the safety and feasibility of the Aliya EX System for the ablation of pulmonary lesions using pulsed electric field (PEF) energy delivery. The study is intended for adult patients with suspected or confirmed pulmonary malignant lesion(s) ≥1.5 cm to ≤4 cm whom are surgical candidates and have not received treatment for the index tumor in the last two years.

Trial Details

NCT ID
NCT07487064
Phase
NA
Sponsor
Galvanize Therapeutics, Inc.
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Aliya Pulsed Electric Field (PEF)
Locations (sample)
  • Shatin, Hong Kong|22.38333,114.18333

Key Eligibility Criteria

  • Presence of at least one lesion in the lung measuring ≥ 1.5 cm and ≤ 4 cm diameter by computed tomography (CT) size estimate deemed suitable for PE…
  • High probability of malignancy as determined by the investigator.
  • Patient has been deemed a candidate for definitive lung tissue resection per institutional SOC.
  • Patient is, in the opinion of the Principal Investigator (PI), able to adhere to and undergo the PEF and surgical procedures.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →